Apyx Medical Corp (APYX) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD $35.33M; Long-term DebtUSD $37.50M; Long-Term Debt, Maturity, Year OneUSD $2.22M; Long-Term Debt, Maturity, Year TwoUSD $35.28M.
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD $35.09M; Long-term DebtUSD $37.50M; Long-Term Debt, Maturity, Year OneUSD $2.22M; Long-Term Debt, Maturity, Year TwoUSD $35.28M.
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD $34.85M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $37.50M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $2.22M.
Apyx Medical Corp Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Current Maturities USD | Long-Term Debt, Maturity, Year Five USD | Short-term Debt, Weighted Average Interest Rate, at Point in Time pure | Line of Credit Facility, Increase (Decrease), Net USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount USD | Notes Payable, Related Parties, Noncurrent USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.33M | $37.50M | $2.22M | $35.28M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $35.09M | $37.50M | $2.22M | $35.28M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $34.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $37.50M | $0.00 | $2.22M | $35.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $34.61M | $37.50M | $0.00 | $2.22M | $35.28M | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $34.37M | $37.50M | $0.00 | $2.22M | $35.28M | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $34.13M | $37.50M | $0.00 | $2.22M | $35.28M | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $33.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $37.50M | $0.00 | $0.00 | $2.22M | $35.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $33.85M | $37.50M | $0.00 | $0.00 | $2.22M | $35.28M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $33.63M | (m) | $0.00 | $0.00 | $2.22M | $35.28M | $0.00 | (m) | (m) | (m) | (m) | $37.50M | (m) | (m) |
| 2024-03-31 | $33.41M | (m) | $0.00 | $0.00 | $2.22M | $35.28M | $0.00 | (m) | (m) | (m) | (m) | $37.50M | (m) | (m) |
| 2023-12-31 | $33.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $0.00 | $0.00 | $0.00 | $2.22M | (m) | (m) | $35.28M | (m) | (m) | $37.50M | (m) | (m) |
| 2023-09-30 | $9.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $8.89M | $0.00 | $2.78M | $3.33M | $3.33M | $0.00 | $8.89M | (m) | (m) | (m) | $10.00M | $658.00K | (m) |
| 2023-03-31 | (m) | $8.78M | $0.00 | $2.78M | $3.33M | $3.33M | $0.00 | $8.78M | (m) | (m) | (m) | $10.00M | $737.00K | (m) |
| 2022-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $100.00K |
| 2018-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $2.33M | $2.57M | $120.00K | $2.45M | (m) | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $2.40M | $2.63M | $239.00K | $2.40M | (m) | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $2.46M | (m) | (m) | (m) | (m) | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $2.69M | $239.00K | $2.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $2.52M | $2.75M | $60.00K | $239.00K | $2.46M | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $2.58M | $2.81M | $120.00K | $239.00K | $2.46M | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $2.63M | $2.87M | $180.00K | $239.00K | $2.46M | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $2.69M | (m) | (m) | (m) | (m) | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $2.93M | $239.00K | $239.00K | $2.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $140.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.03% | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $140.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.96% | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $140.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.94% | (m) | (m) | (m) | (m) |
| 2015-12-31 | $2.93M | (m) | (m) | (m) | (m) | (m) | (m) | $239.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $140.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $239.00K | $2.93M | (m) | (m) | (m) | (m) | (m) | 3.74% | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $239.00K | $239.00K | $2.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $3.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $3.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.00M | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $1.00M | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $1.00M | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-1.00M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |